Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-037552

Co-Chief Executive Officer sold 15,500 shares at $14.68 ($227,593)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Joshua B Co-Chief Executive Officer 2026-02-02 Sale −15,500 $14.68 $227,593 3,363,965 D: show line 1 in the form
Open-market sales · 15,500 sh · avg $14.68 · $227,593
Loading xslF345X05/ownership.xml…